0001379491-22-003859.txt : 20221129 0001379491-22-003859.hdr.sgml : 20221129 20221129104656 ACCESSION NUMBER: 0001379491-22-003859 CONFORMED SUBMISSION TYPE: 497 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20221129 DATE AS OF CHANGE: 20221129 EFFECTIVENESS DATE: 20221129 FILER: COMPANY DATA: COMPANY CONFORMED NAME: FIDELITY SECURITIES FUND CENTRAL INDEX KEY: 0000754510 IRS NUMBER: 000000000 STATE OF INCORPORATION: MA FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: 497 SEC ACT: 1933 Act SEC FILE NUMBER: 002-93601 FILM NUMBER: 221429332 BUSINESS ADDRESS: STREET 1: 245 SUMMER STREET CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 617-563-7000 MAIL ADDRESS: STREET 1: 245 SUMMER STREET CITY: BOSTON STATE: MA ZIP: 02210 0000754510 S000007195 Fidelity Blue Chip Growth Fund C000019693 Fidelity Blue Chip Growth Fund FBGRX C000064269 Class K FBGKX 0000754510 S000007196 Fidelity Blue Chip Value Fund C000019694 Fidelity Blue Chip Value Fund FBCVX 0000754510 S000042624 Fidelity Series Blue Chip Growth Fund C000131779 Fidelity Series Blue Chip Growth Fund FSBDX 0000754510 S000057284 Fidelity Blue Chip Growth K6 Fund C000182860 Fidelity Blue Chip Growth K6 Fund FBCGX 497 1 filing989.htm PRIMARY DOCUMENT

Supplement to the
Fidelity® Blue Chip Growth Fund and Fidelity® Blue Chip Value Fund
September 29, 2022
Prospectus 

The Board of Trustees has approved, subject to shareholder approval, a proposal to reclassify Fidelity® Blue Chip Growth Fund as non-diversified. A meeting of the shareholders of the fund is expected to be held early in the second quarter of 2023 to vote on this proposal. If approved, the changes will take effect on May 1, 2023, or the first day of the month following shareholder approval.

Shareholders should read the proxy statement, which contains important information about the proposal, when it becomes available. For a free copy of the proxy statement, please contact Fidelity at 1-800-544-8544. The proxy statement will also be available on the Securities and Exchange Commission’s website (www.sec.gov).


BCF-BCV-22-01
1.798338.115 		November 29, 2022

Supplement to the
Fidelity® Blue Chip Growth Fund
Class K
September 29, 2022
Prospectus 

The Board of Trustees has approved, subject to shareholder approval, a proposal to reclassify Fidelity® Blue Chip Growth Fund as non-diversified. A meeting of the shareholders of the fund is expected to be held early in the second quarter of 2023 to vote on this proposal. If approved, the changes will take effect on May 1, 2023, or the first day of the month following shareholder approval.

Shareholders should read the proxy statement, which contains important information about the proposal, when it becomes available. For a free copy of the proxy statement, please contact Fidelity at 1-800-835-5092. The proxy statement will also be available on the Securities and Exchange Commission’s website (www.sec.gov).


BCF-K-22-01
1.899242.107 		November 29, 2022

Supplement to the
Fidelity® Series Blue Chip Growth Fund
September 29, 2022
Prospectus 

The Board of Trustees has approved, subject to shareholder approval, a proposal to reclassify Fidelity® Series Blue Chip Growth Fund as non-diversified. A meeting of the shareholders of the fund is expected to be held early in the second quarter of 2023 to vote on this proposal. If approved, the changes will take effect on May 1, 2023, or the first day of the month following shareholder approval.

Shareholders should read the proxy statement, which contains important information about the proposal, when it becomes available. For a free copy of the proxy statement, please contact Fidelity at 1-800-544-8544. The proxy statement will also be available on the Securities and Exchange Commission’s website (www.sec.gov).


XS1-22-01
1.9883868.101 		November 29, 2022

Supplement to the
Fidelity® Blue Chip Growth K6 Fund
September 29, 2022
Prospectus 

The Board of Trustees has approved, subject to shareholder approval, a proposal to reclassify Fidelity® Blue Chip Growth K6 Fund as non-diversified. A meeting of the shareholders of the fund is expected to be held early in the second quarter of 2023 to vote on this proposal. If approved, the changes will take effect on May 1, 2023, or the first day of the month following shareholder approval.

Shareholders should read the proxy statement, which contains important information about the proposal, when it becomes available. For a free copy of the proxy statement, please contact Fidelity at 1-800-835-5092. The proxy statement will also be available on the Securities and Exchange Commission’s website (www.sec.gov).


BCFK6-22-01
1.9886694.101 		November 29, 2022